Brind.

Greg Mueller joined Genmab as Executive Vice President, moving from AstraZeneca.

1 report, 0 independent Updated Jul 1

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Genmab AstraZeneca

Keep exploring

The entities involved

Genmab
Danish healthcare company
- Genmab and Incyte have entered into a collaboration to evaluate new cancer treatments.Sat 11:54
- Genmab's results are advancing its ambition to lead in the field of gynecologic oncology.Fri 18:09
AstraZeneca
British-Swedish pharmaceutical company
- AstraZeneca presented trial results for its IMFINZI cancer treatment at the European Society for Medical Oncology (ESMO) Congress in Madrid.Sat 16:57
- Geopolitical instability in the Middle East has led to significant corporate fallout, including the cancellation of Flutter's London Stock Exchange listing and AstraZeneca considering a move to the US market.Sat 07:38

Coverage

Newest first; wire copies grouped

Jul 1Unknown outlet